Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Pediatric Multiple Sclerosis.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Rebif approval application
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
Immunology of Multiple Sclerosis.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Gastro Effects Dog Oral MS Drug Tecfidera
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Neurotrophic and Neuroprotective effects of muscle contraction.
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
10 years of interferon beta-1b (Beta feron therapy.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.

Pages